Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-001370
Filing Date
2014-01-06
Accepted
2014-01-06 16:47:57
Documents
1
Period of Report
2014-01-02

Document Format Files

Seq Description Document Type Size
1 MCMAHON FORM 4 rrd399179.html 4  
1 MCMAHON FORM 4 rrd399179.xml 4 3307
  Complete submission text file 0001181431-14-001370.txt   4668
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 14510581